Stocks · Health care · Pharmaceutical Preparations

Corbus Pharmaceuticals Holdings, Inc.

CRBP Clue Score27
United States Fiscal year ends December CIK 0001595097 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Yong Ben
14 Sep 2026
Director
Sold on a plan
2,000
$7.84
$15.68K
Sean F. Moran
7 Aug 2026
Chief Financial Officer
Sold on a plan
12,000
$10.08
$120.97K
Yuval Cohen
7 Aug 2026
Chief Executive Officer
Sold on a plan
17,000
$10.08
$171.40K
John Kenneth Jenkins
10 Jun 2026
Director
Sold on a plan
4,800
$7.91
$37.99K
Anne Altmeyer
10 Jun 2026
Director
Sold on a plan
2,412
$7.91
$19.09K
Winston Kung
10 Jun 2026
Director
Sold on a plan
2,026
$7.91
$16.03K
Yuval Cohen
13 Feb 2026
Chief Executive Officer
Sold on a plan
13,871
$7.78
$107.95K
Sean F. Moran
13 Feb 2026
Chief Financial Officer
Sold on a plan
4,701
$7.78
$36.59K
Anne Altmeyer
30 May 2025
Director
Sold on a plan
1,392
$7.25
$10.10K
John Kenneth Jenkins
30 May 2025
Director
Sold on a plan
2,783
$7.35
$20.47K
Yuval Cohen
14 Feb 2025
Chief Executive Officer
Sold on a plan
7,134
$8.76
$62.46K
Sean F. Moran
14 Feb 2025
Chief Financial Officer
Sold on a plan
2,792
$8.76
$24.45K

What was left out

Form 4 filings counted 216
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 19
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 1,398,906
History held since 26 Nov 2014